Prodotti
Sistemi e soluzioni per le applicazioni mediche

SmartXide² WH

Possiedi già questo prodotto?
CONTACT US
Nome* :
 
Cognome* :
Nazione* :
select
 
E-mail* :
Telefono* :
Messaggio* :
Inserisci il codice che leggi nell'immagine

Presto il consenso al trattamento dei dati personali (Leggi quì)
accetto non accetto
 
Presto il consenso a ricevere informazioni sui prodotti, gli eventi e le novità DEKA
accetto non accetto
Banner Smartxide2 Wound Healing ING.jpg
A New Light in Wound Healing Management
Applicazioni
Wound Healing
Sorgenti
CO2 - 10600nm

Introduzione

  Dove DEKA fa la differenza

DEKA REVOLUTION FOR ADVANCED WOUND HEALING AND CARE

Chronic wound care has become a top-priority issue for health systems worldwide. The expenditure for wound management has been rising in last years and will experience further growth, due to progressive ageing of population. It is estimated that about 7 million patients are affected by chronic wounds in U.S.A. alone, where US$25 billion dollars are spent annually. The continuous DEKA’s innovation research has revolutionized the field of chronic wounds management thanks to SmartXide2 surgical CO2 laser. SmartXide2 offers a great adjunctive treatment approach in wound therapy, particularly in difficult-to-heal cutaneous wounds, allowing clinicians to achieve unexpected results in wound closures as never before.

  Applicazioni
• Diabetic foot ulcers
• Venous leg ulcers
• Pressure ulcers
• Wound dehiscence
  Plus
PSD® Technology The first RF CO2 laser system with the exclusive Pulse Shape Design Technology (patent pending). It enables the maximum flexibility of the pulse shape: S-pulse, D-pulse, H-pulse, U-pulse and the CW mode, greatly expand the surgical capabilities of the SmartXide2 making it an effective, versatile and powerful system.
EndoScan The only scanning system on the market with single-mirror technology that allows extreme miniaturization. Scan On/Off and centring controlled by microswitch on scanner body.
Power High peak power (more than 200 W) for better results.
Database Integrated protocols designed for wound care management.
Multimedia Features  Integrated photos and video tutorial.
  Testimonial

“I’ve been using the DEKA CO2 laser to treat skin ulcers and wounds for several years, and I regard myself as a pioneer in this field. Chronic wounds have an enormous impact on public health and a devastating one on patients’ daily lives. The problem cuts across many medical disciplines. In fact, patients who come to my surgery present wounds with various etiology (vascular, pressure, traumatic, surgical, iatrogenic, etc.) that fail to respond to usual treatments, even protracted after years, or potentially difficult to heal due to the position, comorbidity or depth. Therefore, they require advanced and innovative treatments. The SmartXide2 laser creates conditions for correct tissue reparation through ulcer debridement and needling. Patients are very satisfied, as the results are noticeable after just a few sessions, with a considerable reduction in pain both during and after the treatment”.

Carlo Mirabella, M.D.
Department of Cellular Therapy and Transfusion Medicine
Careggi University Hospital, Florence - Italy



“I started using the laser for my toughest cases of chronic diabetic foot ulcers, which were usually infected and non-responsive to treatment. The SmartXide2 system has proved really useful both for preparing the wound bed and for deep decontamination, facilitating the tissue-healing process with often surprising results. Indeed, in many cases I have found significantly quicker healing times as well as a better cosmetic outcome. The EndoScan scanning system enables me to perform extremely accurate, uniform treatment, for careful vaporization of fibrin in the ulcer bed even in complex situations that I would be unable to handle adequately with a scalpel. This instrument has not yet fully expressed its potential. New studies we are drawing up on exposed-bone lesions give us cause for great optimism for the near future, showing that SmartXide2 may become the turning point for the treatment of diabetic foot”.


Matteo Monami, M.D.
Diabetic Foot Unit Director - Diabetology
Department Careggi University Hospital, Florence - Italy